Association of Dapagliflozin vs Placebo with Individual Kansas City Cardiomyopathy Questionnaire Components in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial

Alexander Peikert, Alvin Chandra, Mikhail N. Kosiborod, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. De Boer, Adrian F. Hernandez, Sanjiv J. Shah, Stefan P. Janssens, Jan Bělohlávek, C. Jan Willem Borleffs, Dan Dobreanu, Anna Maria Langkilde, Olof Bengtsson, Magnus Petersson, John J.V. McMurrayScott D. Solomon*, Muthiah Vaduganathan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Association of Dapagliflozin vs Placebo with Individual Kansas City Cardiomyopathy Questionnaire Components in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

INIS

Pharmacology, Toxicology and Pharmaceutical Science